150 related articles for article (PubMed ID: 31522377)
1. Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.
Song HY; Son KB; Shin JY; Bae S
Int J Clin Pharm; 2019 Dec; 41(6):1434-1441. PubMed ID: 31522377
[TBL] [Abstract][Full Text] [Related]
2. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
Yao X; Abraham NS; Alexander GC; Crown W; Montori VM; Sangaralingham LR; Gersh BJ; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908412
[TBL] [Abstract][Full Text] [Related]
3. Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack.
Patel PA; Zhao X; Fonarow GC; Lytle BL; Smith EE; Xian Y; Bhatt DL; Peterson ED; Schwamm LH; Hernandez AF
Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):383-92. PubMed ID: 26058721
[TBL] [Abstract][Full Text] [Related]
4. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
Joosten LPT; van Doorn S; Hoes AW; Nierman MC; Wiersma NM; Koek HL; Hemels MEW; Huisman MV; Roes KC; van den Bor RM; Buding WF; Rutten FH; Geersing GJ
BMJ Open; 2019 Dec; 9(12):e032488. PubMed ID: 31888928
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation.
Nam KW; Kwon HM; Lee YS; Won SH; Moon HS; Park JH
Sci Rep; 2024 Apr; 14(1):9838. PubMed ID: 38684879
[TBL] [Abstract][Full Text] [Related]
6. Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Joosten LPT; van Doorn S; van de Ven PM; Köhlen BTG; Nierman MC; Koek HL; Hemels MEW; Huisman MV; Kruip M; Faber LM; Wiersma NM; Buding WF; Fijnheer R; Adriaansen HJ; Roes KC; Hoes AW; Rutten FH; Geersing GJ
Circulation; 2024 Jan; 149(4):279-289. PubMed ID: 37634130
[TBL] [Abstract][Full Text] [Related]
7. The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey.
Potpara TS; Trendafilova E; Dan GA; Goda A; Kusljugic Z; Manola S; Music L; Gjini V; Pojskic B; Popescu MI; Georgescu CA; Dimitrova ES; Kamenova D; Ekmeciu U; Mrsic D; Nenezic A; Brusich S; Milanov S; Zeljkovic I; Lip GYH;
Adv Ther; 2017 Aug; 34(8):2043-2057. PubMed ID: 28795332
[TBL] [Abstract][Full Text] [Related]
8. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P;
Eur Heart J; 2017 Jul; 38(27):2137-2149. PubMed ID: 27282612
[TBL] [Abstract][Full Text] [Related]
9. Survey of Using Oral Anticoagulants in Patient with Non-valvular Atrial Fibrillation.
Dung BT; Hien NT; Hoa T; Han CNM
Med Arch; 2024; 78(1):16-21. PubMed ID: 38481589
[TBL] [Abstract][Full Text] [Related]
10. Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy.
Zhen S; Chu F; Kodesh A; Kim J
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199668
[TBL] [Abstract][Full Text] [Related]
11. In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
Dunn A
Ann Intern Med; 2024 May; 177(5):JC57. PubMed ID: 38710082
[TBL] [Abstract][Full Text] [Related]
12. Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near-Real-Time Monitoring Program in Italy.
Mayer F; Kirchmayer U; Coletta P; Agabiti N; Belleudi V; Cappai G; Di Martino M; Schneeweiss S; Davoli M; Patorno E
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525786
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status.
Varona JF; Seguí-Ripoll JM; Lozano-Duran C; Cuadrado-Gómez LM; Montagud-Moncho JB; Ramos-Guerrero A; Mirete-Ferrer JC; Donado E; García-Alegría J;
Health Qual Life Outcomes; 2020 Dec; 18(1):383. PubMed ID: 33308246
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study.
Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AC; Kalaycioğlu E; Bolat I; Taşar O; Şafak Ö; Kalcik M; Yaman M; İnci S; Altintaş B; Kalkan S; Kirma C; Biteker M;
Medicine (Baltimore); 2016 Aug; 95(35):e4672. PubMed ID: 27583892
[TBL] [Abstract][Full Text] [Related]
15. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation.
Kim J; Kang D; Kim H; Park H; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY
J Korean Med Sci; 2024 Jun; 39(24):e191. PubMed ID: 38915283
[TBL] [Abstract][Full Text] [Related]
16. Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation.
Mangner N; Brinkert M; Keller LS; Moriyama N; Hagemeyer D; Haussig S; Crusius L; Kobza R; Abdel-Wahab M; Laine M; Stortecky S; Pilgrim T; Nietlispach F; Ruschitzka F; Thiele H; Toggweiler S; Linke A
EuroIntervention; 2023 Feb; 18(13):e1066-e1076. PubMed ID: 36440479
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug interactions with non-vitamin-K oral anticoagulants on thromboembolic events in patients with nonvalvular atrial fibrillation.
Chen JH; Lee MC; Yen TH; Huang PY; Lu DE; Lee CH; Chang HC; Wang JY; Lee JA
Ann Acad Med Singap; 2024 Feb; 53(2):69-79. PubMed ID: 38920231
[TBL] [Abstract][Full Text] [Related]
18. The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease.
Simic J; Mihajlovic M; Zec N; Kovacevic V; Marinkovic M; Mujovic N; Potpara T
Expert Rev Cardiovasc Ther; 2023; 21(12):937-945. PubMed ID: 37842943
[TBL] [Abstract][Full Text] [Related]
19. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence.
Hajra A; Ujjawal A; Ghalib N; Chowdhury S; Biswas S; Balasubramanian P; Gupta R; Aronow WS
Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102017. PubMed ID: 37544618
[TBL] [Abstract][Full Text] [Related]
20. Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.
Kozieł M; Teutsch C; Bayer V; Lu S; Gurusamy VK; Halperin JL; Rothman KJ; Diener HC; Ma CS; Huisman MV; Lip GYH;
J Arrhythm; 2021 Aug; 37(4):990-1006. PubMed ID: 34386125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
